Status:
COMPLETED
Evaluation of OE-MRI in Patients With H&N Cancer
Lead Sponsor:
Nottingham University Hospitals NHS Trust
Conditions:
Head and Neck Squamous Cell Carcinoma
Eligibility:
All Genders
18-99 years
Brief Summary
Assessment of the use of oxygen enhanced MRI scanning in a cohort of patients with head and neck squamous cell carcinomas to identify areas of hypoxia with tumours and relate this to treatment outcome...
Detailed Description
Oxygen-enhanced MRI (OE-MRI) is a technique being actively investigated for imaging hypoxia within cancer tissues. Preliminary clinical data demonstrates the feasibility of using this methodology to s...
Eligibility Criteria
Inclusion
- Non-patient Volunteer
- Age 18 years and above
- Signed written informed consent
- Patient
- Histologically proven or strong clinical suspicion of squamous cell carcinoma of the head and neck
- Suitable for undergoing radical radiotherapy or chemoradiotherapy according to local protocols within the head and neck Cancer MDT
- Age 18 years and above
- Adequate physical fitness (WHO performance status 0 to 2)
- Signed written informed consent
Exclusion
- Non-patient Volunteer
Key Trial Info
Start Date :
March 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2023
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04724096
Start Date
March 4 2021
End Date
February 1 2023
Last Update
May 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queens Medical Centre
Nottingham, Nottinghamshire, United Kingdom, NG7 2UH